Skip to content
OpenCapital
Get started

Enovis ENOV Reconstructive — Net Sales

Other segment segments

Prevention & Recovery
$272.02M—

Similar metrics at other companies

TFX
TFXSurgical — Net revenues
$106.79M+12.4%
Stryker logo
SYKOrthopaedics: — Net Sales
$2.81B+0.1%
DENTSPLY SIRONA logo
XRAYImplants & Prosthetics — Net Sales
$154M-2.5%
CONMED logo
CNMDOrthopedic Surgery — Net Sales
$147.66M+6.8%
IAR
IARTWound Reconstruction — Total Revenues
$79.65M+6.5%
IAR
IARTTissue Reconstruction — Total Revenues
$108.78M+6.7%

Other financials

Income statement

See full
Revenue$589.2M+5.4%
Gross profit$365.5M+10.0%
Operating income$6.5M+114%
Net income-$8.8M+84.3%
EPS (diluted)-$0.15+84.7%

Balance sheet

See full
Cash & equivalents$33.1M-13.9%
Total debt$1.4B-3.1%
Total equity$1.5B-43.6%
Total assets$3.8B-21.4%

Cash flow

See full
Operating cash flow$24.0M+1,601%
CapEx$52.8M+22.1%
Free cash flow-$28.9M+35.7%

Valuation

See full
Market cap$1.23B-28.4%
Enterprise value$2.55B-17.1%
P/S0.5×-0.3×

Profitability

See full
Gross margin60.5%+4.0pp
Operating margin-47%+18.6pp
Net margin-49.9%+24.1pp
FCF margin-3.1%-1.1pp

Returns & leverage

See full
Return on equity-55.5%-1,722pp
Debt / equity0.9×+0.4×
Current ratio2×-0.5×

Where this comes from

Reported directly by Enovis in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Enovis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Enovis's reconstructive — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Enovis's reconstructive — net sales?
Enovis (ENOV) reported reconstructive — net sales of $317.13M in Q1 2026.
How has Enovis's reconstructive — net sales changed year-over-year?
Enovis's reconstructive — net sales increased by 10.8% year-over-year, from $286.25M to $317.13M.
What is the long-term trend for Enovis's reconstructive — net sales?
Over 4 years (2021 to 2025), Enovis's reconstructive — net sales has grown at a 29.1% compound annual growth rate (CAGR), from $400.16M to $1.11B.
What does reconstructive — net sales mean?
The total revenue generated from the sale of reconstructive medical devices and services, net of returns, allowances, and discounts. It serves as the primary indicator of market demand and the segment's competitive position within the orthopedic and surgical industry.